Group leader Michelle Linterman joined the Nine to Noon show on Radio New Zealand to discuss her research on ageing, the immune system and vaccination.
Impact of brain injury, stroke and MS reduced in mice by scientists at Babraham Institute and KU Leuven
Gene switch system offers hope to patients
Prof Wolf Reik and Dr Diljeet feature in a number of articles and appearances in relation to their recent publication.
Freelance journalist Katharine Sanderson writes about the innovative Roving Researcher scheme.
Paul Brackley reports that researchers have discovered a new population of stem cells
Ian Sample writes about the new stem cell rejuvenation method developed in the Reik lab.
Prof Liston describes the potential for treatments based on autoantibodies.
Simon Cook and Derek Jones write about how to prepare students of a diversity of careers in science across sectors.
Paul Brackley covers 'flu vaccine research.
Peter Rugg-Gunn provides expert comment on gastrulation study.
Andy Martin asks the question: Who wants to live forever?
Mike Scialom covers a new development for Dr Nicholas Ktistakis' Milner Consortium collaboration.
Peter Brackley speaks to Wolf Reik about his new role.
The Mail Online reports on a new model similar to human blastocysts, with expert comment from Peter Rugg-Gunn.
In this extended interview published in the Cambridge Independent, Adrian Liston explains the science behind vaccines and the immune response.
Michelle Linterman interviewed on her important COVID-19 research in mice by Cambridge Independent editor Paul Brackley.
Newly appointed board members Wolf Reik, Alexander Hewitson, and Clive Stanway speak to the Cambridge Independent.
The Epigenetics Podcast interviews Wolf Reik about his career in epigenetics.
Michelle Linterman is interviewed by 95bFM host Zoë Larsen Cumming about her COVID19 vaccine research.
Wolf Reik explains the concept of the biological clock to science writer Tom Chivers for his article exploring mortality.
The Cambridge Independent covers Rahul Roychoudhuri’s recently published research in collaboration with the Wellcome Sanger Institute.
Michelle Linterman talks to Medicine Maker reporter Stephanie Sutton about her drug repurposing findings.